Cancer heat therapy-enhancing agent

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9012502
APP PUB NO 20130158293A1
SERIAL NO

13820303

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is an enhancer for cancer thermotherapy not combined with photodynamic therapy. Cancer treatment not combined with photodynamic therapy is made available by using, as an enhancer for cancer thermotherapy, 5-aminolevulinic acids represented by formula (1):

description='In-line Formulae' end='lead'R2R1NCH2COCH2CH2COR3  (1)description='In-line Formulae' end='tail'

[wherein R1 and R2 each independently represent a hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group, an aryl group, or an aralkyl group; and R3 represents a hydroxy group, an alkoxy group, an acyloxy group, an alkoxycarbonyloxy group, an aryloxy group, an aralkyloxy group, or an amino group] or a salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SBI PHARMACEUTICALS CO LTD6-1 ROPPONGI 1-CHOME MINATO-KU TOKYO 106-6020

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abe, Fuminori Tokyo, JP 18 98
Chibazakura, Taku Tokyo, JP 2 14
Nakajima, Motowo Tokyo, JP 40 175
Takahashi, Kiwamu Tokyo, JP 78 336
Tanaka, Tohru Tokyo, JP 88 464

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 21, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00